nucleocapsid
protein
play
critic
role
sarscov
pathogenesi
highlevel
antinucleocapsid
antibodi
detect
patient
infect
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
sever
studi
shown
exist
interact
nucleocapsid
n
membran
protein
paper
investig
whether
express
membran
protein
affect
immun
respons
induc
nucleocapsid
dna
immun
two
recombin
plasmid
contain
n
code
sequenc
construct
moreov
order
get
antigen
elisa
vitro
stimul
assay
n
protein
express
purifi
e
coli
bacteria
inject
g
mixtur
balbc
mice
could
elicit
humor
cellular
respons
elisa
analysi
use
n
antigen
inactiv
sarscov
particl
captur
antigen
show
coinject
sarsm
could
enhanc
ninduc
antibodi
product
especi
subclass
lymphocyt
stimul
gml
purifi
n
antigen
cell
n
plu
n
group
increas
compar
control
group
protein
could
augment
activ
lymphocyt
induc
n
dna
vaccin
cytokin
elisa
analysi
reveal
coinject
could
enhanc
level
releas
induc
n
antigen
experi
field
mous
also
support
claim
membran
protein
augment
nspecif
immun
respons
viru
challeng
test
conduct
bio
safeti
laboratori
brandt
vole
sarscov
model
result
indic
coimmun
n
antigen
could
reduc
mortal
patholog
chang
lung
viru
infect
syndrom
call
sever
acut
respiratori
syndrom
sar
infect
peopl
earli
kill
http
genom
sarscov
sequenc
sever
independ
group
sar
genom
singapor
canada
hongkong
guangzhou
beij
china
remain
unchang
infect
spread
http
suggest
genet
vaccin
mayb
effici
approach
protect
sarscov
infect
sarscov
genom
contain
five
major
open
read
frame
orf
encod
replicas
polyprotein
spike
envelop
e
glycoprotein
n
protein
order
approxim
size
coronavirus
kathryn
lui
gene
encod
protein
amino
acid
analysi
protein
reveal
amino
acid
hydrophil
domain
insid
viru
particl
believ
interact
n
protein
qin
et
al
report
exist
interact
sarscov
n
protein
stretch
amino
acid
n
protein
may
critic
proteinprotein
interact
et
al
whether
interact
play
role
immun
respons
induc
sarscov
infect
clear
complet
n
protein
contain
amino
acid
possibl
n
protein
play
critic
role
sarscov
pathogenesi
addit
basic
natur
peptid
suggest
may
assist
rna
bind
marra
et
al
previou
studi
n
protein
repres
antigen
tcell
respons
vaccin
set
gao
et
al
mice
vaccin
calreticulin
crt
n
dna
capabl
significantli
reduc
titer
challeng
vaccinia
viru
express
n
protein
sar
viru
kim
et
al
report
n
dna
vaccin
could
induc
sarsspecif
tcell
prolifer
cytotox
cell
activ
experi
demonstr
sarsn
administr
could
induc
virusspecif
cellular
respons
human
cell
use
scidpblhu
mous
model
jin
et
al
okada
et
al
although
sera
obtain
convalesc
sar
patient
antibodi
n
tan
et
al
n
antigen
induc
detect
serum
sarscovneutr
antibodi
respons
mice
buchholz
et
al
taken
account
insert
full
n
gene
inocul
mice
brandt
vole
microtu
brandti
radd
n
dna
alon
togeth
investig
immun
respons
induc
dna
immun
previou
studi
develop
sarscov
infect
anim
model
brandt
vole
gao
et
al
select
anim
challeng
test
assess
capac
plu
n
dna
immun
femal
balbc
mice
purchas
institut
genet
chines
academi
scienc
brandti
radd
obtain
dr
wang
dehua
institut
zoolog
chines
academi
scienc
mice
kept
control
condit
light
temperatur
free
access
standard
mous
chow
water
experi
conduct
accord
guidelin
beij
anim
care
laboratori
anim
protocol
approv
anim
care
use
committe
institut
zoolog
chines
academi
scienc
n
plasmid
contain
fulllength
sarscov
n
cdna
kindli
provid
professor
yang
huanm
institut
genom
chines
academi
scienc
fulllength
n
gene
cut
bamhi
xba
ligat
correspond
restrict
site
vector
invitrogen
carlsbad
ca
creat
pair
primer
contain
ndei
bamhi
enzym
site
use
amplifi
n
complet
gene
fragment
digest
ndei
bamhi
insert
novagen
madison
wi
usa
cut
enzym
three
recombin
confirm
restrict
digest
sequenc
balbc
mice
n
divid
two
control
four
experiment
group
vole
n
divid
one
control
three
experiment
group
mice
one
experiment
group
inject
g
plu
g
leg
muscl
threespot
inject
week
three
time
mice
experiment
group
receiv
g
n
alon
togeth
experiment
vole
receiv
g
n
recombin
alon
togeth
anim
inject
l
bupivacainehcl
sigma
saint
loui
mo
h
dna
inocul
control
group
inject
way
equal
volum
mock
vector
salin
use
inject
techniqu
schedul
shi
et
al
examin
vivo
express
vaccin
total
rna
isol
muscl
inject
site
treat
dnase
boehhring
mannheim
indianapoli
delet
interfer
dna
pair
primer
use
detect
n
express
mrna
level
pair
prime
use
mrna
amplif
rtpcr
product
detect
agaros
gel
sequenc
pcr
reaction
without
rt
also
conduct
order
rule
possibl
dna
contamin
elisa
vitro
stimul
assay
n
protein
express
bacteria
purifi
affin
column
e
coli
use
clone
host
empti
cell
grown
luriabertani
medium
supplement
ampicillin
gml
two
four
h
induct
mm
isopropyl
dthiogalactopyranosid
cell
harvest
wash
twice
cold
buffer
mm
mm
edta
ph
resuspend
buffer
lysozym
triton
ad
final
concentr
gml
respect
mixtur
incub
c
min
centrifug
g
supernat
cell
lysat
resuspend
sdspage
load
buffer
place
boil
water
bath
min
electrophores
crack
et
al
protein
sampl
sd
page
gel
stain
coomassi
blue
hitrap
affin
column
amersham
bioscienc
use
purif
recombin
n
tag
protein
follow
product
instruct
protein
purif
detect
western
blot
ninetysixwel
microtit
plate
costar
coat
l
gml
n
protein
per
well
dilut
bicarbon
buffer
ph
overnight
c
wash
three
time
pbst
pb
block
bsapb
room
temperatur
h
wash
three
time
l
sera
serial
dilut
start
normal
goat
sera
supplement
ad
well
extens
wash
antibodi
detect
goat
antimous
igg
conjug
horseradish
peroxidas
sigma
dilut
pbst
contain
normal
goat
sera
ad
substract
reaction
stop
h
absorb
measur
wavelength
nm
titer
valu
mous
antibodi
assign
highest
dilut
optic
densiti
equal
time
absorb
produc
serum
preimmun
mice
equival
dilut
lymphocyt
mice
isol
cultur
sixwel
flatbottom
plate
cellsml
gibcobrl
rockvil
md
contain
fetal
calf
serum
hyclon
sigma
week
immun
purifi
n
protein
pass
filter
kda
cutoff
millipor
remov
low
molecular
weight
product
elut
buffer
gml
n
protein
ad
medium
day
cultur
medium
supplement
recombin
peprotech
ec
london
uk
uml
three
day
stimul
lymphocyt
harvest
resuspend
flow
cytometr
analysi
buffer
fc
block
cell
stain
phycoerythrin
pe
label
clone
souther
biotech
birmingham
al
fluorescein
isothiocyan
fitc
label
clone
souther
biotech
isotyp
control
antibodi
h
wash
twice
cell
analyz
facscalibur
flow
cytomet
cho
et
al
supernat
lymphocyt
cultur
harvest
subject
measur
elisa
detect
kit
r
system
valu
cytokin
express
concentr
pgml
accord
standard
sampl
curv
valu
well
incub
pb
blank
l
per
well
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
contain
gml
n
antigen
ad
plate
costar
bovin
serum
albumin
bsa
promega
madison
wi
gml
set
nonspecif
antigen
control
ad
l
approxim
cellswel
lymphocyt
suspens
immun
vole
per
well
plate
incub
humidifi
co
incub
c
day
human
recombin
sigma
ad
cultur
medium
uml
day
l
celltit
aqueou
one
solut
reagent
promega
ad
well
plate
incub
h
c
absorb
sampl
nm
read
biorad
result
defin
stimul
index
si
ratio
nm
n
antigen
neg
control
microtit
plate
costar
coat
inactiv
sarscov
particl
follow
experiment
process
valu
nm
equal
consid
posit
previou
studi
absorb
valu
experiment
mice
equal
mean
valu
mous
neg
group
liang
gd
unpublish
data
fourteen
adult
brandti
radd
divid
two
group
two
week
anim
immun
mock
vector
n
n
vaccin
n
three
time
anim
challeng
live
sarscov
previou
report
gao
et
al
qin
et
al
two
vole
die
anesthesia
manipul
histolog
perform
repres
section
lung
liver
kidney
spleen
brain
heart
pancrea
intestin
stomach
thymu
lymph
node
bladder
bone
marrow
testicl
prostat
ovari
uteru
tissu
field
mice
challeng
paraffin
embed
stain
haematoxylin
eosin
stain
experi
conduct
bio
safeti
laboratori
valu
except
special
explan
report
mean
sem
statist
analysi
perform
use
one
wayanova
differ
consid
statist
signific
p
identifi
express
vivo
presenc
n
mrna
mice
muscl
immun
vaccin
mock
dna
analyz
rtpcr
reaction
design
primer
use
detect
n
express
desir
fulllength
cdna
nucleotid
acid
n
cdna
nucleotid
acid
thu
proven
express
immun
mice
muscl
fig
band
detect
reaction
conduct
without
rt
process
data
shown
n
protein
ctermin
histidin
tag
express
bacteria
induct
iptg
volum
desir
protein
increas
fig
solubl
protein
bacteria
treat
hitrap
affin
column
treat
two
band
remain
sdspage
gel
fig
bold
band
repres
fulllength
n
protein
expect
molecular
weight
fig
igg
titer
specif
n
antigen
mice
sera
serial
dilut
detect
standard
elisa
log
titer
shown
fig
show
ninduc
igg
increas
coinject
p
wherea
signific
differ
group
immun
g
n
vaccin
alon
group
g
n
plu
g
mock
dna
p
indic
antibodi
enhanc
contribut
plasmid
dna
n
antibodi
sera
immun
dna
vaccin
time
preimmun
sera
n
log
valu
antibodi
titer
express
one
without
bar
tabl
observ
igg
induc
n
dna
immun
mous
vole
increas
coinject
mous
antibodi
assay
show
mostli
increas
subclass
nspecif
igg
induc
stain
cell
analyz
fac
scan
activ
gate
cell
cell
group
immun
n
combin
group
immun
n
vaccin
alon
addit
signific
differ
activ
cell
group
immun
n
dna
vaccin
alon
mock
plu
n
p
p
demonstr
n
dna
vaccin
could
induc
tcell
mediat
respons
mice
express
could
enhanc
lymphocyt
activ
induc
n
vaccin
stimul
n
antigen
lymphocyt
group
immun
n
n
combin
mock
secret
signific
level
compar
control
group
moreov
lymphocyt
group
plu
n
releas
cytokin
group
immun
n
vaccin
fig
detect
nspecif
antibodi
immun
mice
antibodi
respons
n
n
bled
day
last
immun
mean
titer
antibodi
evalu
elisa
valu
express
log
defin
posit
use
absolut
ratio
postnaiv
serum
cutoff
level
increas
twoand
respect
tabl
activ
prolifer
lymphocyt
play
critic
role
humor
cellular
immun
respons
induc
vaccin
shown
fig
higher
level
activ
lymphocyt
stimul
gml
n
antigen
observ
anim
immun
n
alon
mixtur
n
compar
control
moreov
lymphocyt
prolifer
specif
n
antigen
stronger
vole
immun
n
anim
immun
n
fig
lymphocyt
prolifer
assay
four
week
last
immun
vole
sacrif
singl
lymphocyt
suspens
cultur
medium
approxim
cell
ad
well
gml
purifi
n
antigen
use
stimul
lymphocyt
prolifer
activ
day
l
mt
solut
ad
well
plate
incub
h
c
absorb
sampl
nm
read
result
express
stimul
index
si
ratio
absorb
od
nm
n
antigen
neg
control
data
express
mean
sem
fig
antisarscov
anim
experi
adult
microtu
brandti
radd
inocul
n
n
mock
n
challeng
sarscov
fourteen
day
challeng
number
mice
die
patholog
chang
lung
show
reaction
igg
antibodi
complet
sarscov
particl
sera
detect
elisa
result
indic
mice
immun
n
togeth
vaccin
could
produc
posit
reaction
inactiv
sarscov
n
valu
howev
sera
mice
immun
mock
n
plasmid
alon
n
could
fig
show
brandti
radd
immun
plu
n
die
week
challeng
sarscov
wherea
anim
immun
mock
vector
die
result
care
observ
microscop
examin
syndrom
vole
challeng
viru
like
infect
syndrom
human
data
microscop
inspect
show
vole
challeng
viru
obviou
patholog
chang
lung
wherea
one
seven
anim
inocul
mixtur
n
patholog
chang
lung
vole
challeng
live
sarscov
pulmonari
alveoli
control
anim
destroy
extens
haemorrhag
inflamm
cell
invas
pulmonari
space
compress
also
observ
lung
section
fig
moreov
variabl
featur
includ
kidney
spleen
liver
haemorrhag
variabl
amount
multinucl
giant
cell
monocyt
detect
howev
lung
patholog
chang
found
one
seven
vole
immun
plu
n
featur
alveolar
cell
hyperplasia
calcifi
kidney
tubul
obviou
patholog
chang
observ
lung
liver
kidney
organ
inspect
six
vaccin
anim
studi
success
construct
express
plasmid
contain
fulllength
n
cdna
isol
sar
patient
kill
diseas
vivo
vitro
assay
data
shown
demonstr
vaccin
could
express
eukaryot
cell
order
get
n
protein
detect
specif
antibodi
tcell
mediat
respons
construct
prokaryot
express
plasmid
recombin
could
correctli
express
n
protein
bacteria
express
volum
increas
induc
iptg
elisa
analysi
demonstr
coexpress
n
protein
could
enhanc
product
nspecif
antibodi
balbc
major
increas
antibodi
subclass
balbc
consist
immunorespons
result
help
us
explain
observ
highlevel
nucleocapsid
antibodi
found
patient
infect
sarscov
sinc
plasmid
dna
potenti
adjuv
order
rule
possibl
immun
enhanc
contribut
differ
amount
plasmid
dna
nspecif
antibodi
mice
immun
mock
plu
sarsn
measur
result
reveal
signific
group
mock
plu
n
n
use
complet
sarscov
captur
antigen
elisa
assay
show
absorb
valu
sampl
mice
immun
n
togeth
posit
wherea
sera
n
vaccin
immun
mice
neg
tcell
mediat
cellular
respons
import
assess
efficaci
antivir
vaccin
studi
show
stimul
lymphocyt
gml
n
antigen
lymphocyt
mice
immun
n
n
vaccin
mice
inject
mock
alon
coexpress
n
enhanc
cell
activ
n
antigen
cellmedi
cytotox
anoth
essenti
defens
viral
pathogen
cytotox
cell
recogn
specif
antigen
present
mhc
class
sarsm
enhanc
cell
activ
specif
n
antigen
indic
could
augment
cytotox
provok
n
dna
immun
tcellderiv
cytokin
releas
repres
import
defens
mechan
viru
infect
product
cytokin
lymphocyt
immun
plu
n
stimul
signific
increas
compar
lymphocyt
immun
n
accor
danc
result
major
increas
antibodi
subclass
n
antigen
induc
experi
antisarscov
brandti
radd
support
immun
induc
n
combin
dna
immun
could
protect
anim
viru
challeng
clear
administr
enhanc
ninduc
antibodi
product
lymphocyt
activ
sinc
analysi
protein
reveal
amino
acid
hydrophil
domain
insid
viru
particl
believ
interact
n
protein
addit
mammalian
twohybrid
assay
prove
possibl
interact
sarscov
n
protein
et
al
suppos
n
antigen
mayb
reveal
bcell
tcell
epitop
protein
interact
previou
studi
link
marek
diseas
viru
type
new
castl
diseas
viru
antigen
could
improv
dna
vaccin
potenc
hung
et
al
termeer
et
al
antigen
also
viru
antigen
suppos
enhanc
efficaci
n
dna
vaccin
accord
antigen
potenti
new
adjuv
predict
basic
natur
n
peptid
may
assist
rna
bind
novel
nuclear
function
play
import
role
pathogenesi
sarscov
dna
construct
encod
crt
link
sarscov
n
antigen
capabl
gener
strong
nspecif
humor
cellular
immun
respons
may
potenti
use
control
infect
sarscov
gao
et
al
although
antibodi
specif
n
signific
protect
efficaci
mous
model
data
protein
enhanc
specif
immun
induc
n
dna
immun
help
investig
sar
pathogenesi
cours
sarscov
infect
design
potenti
vaccin
base
tcellmed
respons
